drugset
drugset / Trial / NCT02963324

Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers

NCT02963324 ↗

Phase 1 Completed 12 enrolled University Hospital, Basel, Switzerland
NaSingle-groupOpen-labelBasic science

Summary

The present study assesses the pharmacokinetic profile of Ivermectin (IVM) in healthy human volunteers and aims to create a physiologically-based pharmacokinetic model. Planned indication is the prevention of malaria transmission.

Timeline

Start
2016-11
Primary completion
2016-12
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivermectin Small molecule 12 mg Oral

Indications

malaria